Before You Compare Collagen OEM Quotes
KS Nutripharma manufactures collagen supplements as finished OEM / ODM / private-label SKUs. Quotes are comparable only after source, type, peptide method, format, and annual volume are on the brief.
Buyer Snapshot
| Your decision | What to send on the RFQ |
|---|---|
| What you are buying | Finished collagen SKU under your brand |
| Source and type | Marine, bovine, porcine, or chicken — Type I / II / III declared on COA |
| Peptide spec | MW statistic and method; protein method agreed (Kjeldahl or Dumas) |
| Format | Powder, stick, capsule, softgel, liquid, or gummy |
| Starting blueprint | Formula 03 unless the brief already specifies another card |
| Typical starting MOQ | Capsules 3,000–5,000 · powder / sticks 1,000–3,000 · gummies 5,000–10,000 units / SKU |
| Indicative timing | Sample 7–15 days · commercial typically 30–45 days after formula, pack, and artwork lock |
| Docs | Spec · COA · metals / micro · traceability · destination file list |
Which collagen SKU are you quoting — and for which channel?
Type I beauty, Type II joint, and marine collagen SKUs require different specifications and production parameters. Lock the source, type, format, serving, and channel before comparing quotes.
Pick a starting architecture — 20 collagen formula blueprints
Reference formulas based on established market architectures — adjust source, dose, actives, flavor, and dosage form for your target market. OEM starting points, not copies of any brand formula, and not a sales ranking. Send the card number plus your changes (source, grams, flavor, format).
A. High-volume powders and drinks — start here if you need a daily SKU ( Formula 1-5)
B. Premium beauty and dual-delivery — start here if oil-solubles or marine odor are on the brief ( Formula 6-12)
C. Multi-source collagen — start here only if the label needs more than one species ( Formula 13-15)
D. Type II joint programs — do not quote these as beauty Type I (Formula 16-17)
E. Hybrid and botanical SKUs — start here if plant peptides or botanicals are required ( Formula 18-20)
Positioning: Multi-source collagen powder
| Component | Starting specification |
|---|---|
| Bovine collagen (Type I / III) | Part of 10–20 g total |
| Marine collagen (Type I) | Part of 10–20 g total |
| Chicken collagen (Type II) | Part of 10–20 g total |
| Eggshell membrane | Optional |
| Total collagen peptides | 10–20 g / day |
| Format | Powder |
| Best fit | Multi-source daily powder |
Commercial logic: Multi-source raises complexity, sourcing, and label/specification load — not a quality score.
Adjustment options: Two sources vs four; declare each type on COA.
Development constraints: Species identity · Type II vs Type I split · odor · metals on the marine fraction.
Positioning: Multi-source + short beauty stack
| Component | Starting specification |
|---|---|
| Multi-collagen blend | 8–15 g |
| Hyaluronic acid | 60–120 mg |
| Vitamin C | 100–200 mg |
| Biotin | 100–2,500 μg |
| Zinc | 5–10 mg |
| Vitamin E | 10–20 mg |
| Format | Powder |
| Best fit | Multi-source beauty powder / subscription SKU |
Commercial logic: Formula 13 plus HA, biotin, and vitamins.
Adjustment options: Hold keratin / extra B-vitamins unless the brief needs Formula 12.
Development constraints: Identity of each source · moisture · flavor.
Positioning: Beauty + digestive powder
| Component | Starting specification |
|---|---|
| Collagen peptides (single or multi-source) | 10–20 g |
| Vitamin C | 60–200 mg |
| Bacillus coagulans | 1–2 billion CFU |
| Format | Powder |
| Best fit | High-dose powder with spore probiotic |
Commercial logic: High peptide dose plus spore-forming probiotic.
Adjustment options: Strain and CFU at end of shelf life — not in-process CFU.
Development constraints: Moisture · processing temperature · flavor · CFU at expiry.
Positioning: Joint / mobility capsule — not a beauty Type I powder
| Component | Starting specification |
|---|---|
| Undenatured Type II collagen | ~10–40 mg, per ingredient specification |
| Boron | ~1–3 mg |
| Vitamin D3 | Market-dependent |
| Format | Tablet · capsule |
| Best fit | Small daily tablet / practitioner or pharmacy |
Commercial logic: Milligram-scale Type II; different identity from Formula 01–15.
Adjustment options: Dose follows the Type II supplier spec — do not scale as hydrolyzed Type I grams.
Development constraints: Identity · undenatured handling · destination-market substantiation.
Positioning: Skin + joint crossover complex
| Component | Starting specification |
|---|---|
| Hydrolyzed Type II collagen | ~720 mg (adjust to complex spec) |
| Chondroitin sulfate | ~192 mg |
| Hyaluronic acid | ~120 mg |
| Vitamin C | ~100 mg |
| Format | Capsule · tablet |
| Best fit | Type II complex capsule — not a 20 g beauty powder |
Commercial logic: Defined Type II / HA / chondroitin ratio from the complex spec.
Adjustment options: Match the Type II complex supplier ratio; do not rebuild from Type I grams.
Development constraints: Assay of each fraction · capsule fill · claim language.
Positioning: Healthy-aging beauty (separate formula roles)
| Component | Starting specification |
|---|---|
| Collagen peptides | 5–10 g |
| Vitamin C | 100–200 mg |
| Grape seed extract | 50–150 mg |
| Pomegranate extract | 100–250 mg |
| Vitamin E | 10–20 mg |
| Format | Powder · capsule |
| Best fit | Botanical beauty powder or capsule |
Commercial logic: Peptide and botanicals as separate components — not an absorption story.
Adjustment options: Extract assay and solvent residues on the brief.
Development constraints: Color · astringency · moisture · botanical–peptide flavor.
Collagen is an animal connective-tissue protein. Common commercial collagen sources include marine, bovine, porcine, and chicken-derived materials. Specify collagen type separately from source. Type I, II, and III are collagen classifications, not raw-material grades.
| Source | Typical types | Common formulation use | Procurement note | Key controls |
|---|---|---|---|---|
| Marine | Type I | Beauty / skin-focused SKUs | Odor and contaminant panels differ from hide collagen | Odor retain · metals (As, Hg, Pb, Cd) · species declaration · traceability |
| Bovine | Type I / III | Beauty · structural / multi-collagen | Type III claims require source and specification evidence; unsupported type claims can create labeling or retailer-compliance issues | Traceability · species · Halal / Kosher where claimed |
| Porcine | Type I / III | Peptide powders and capsules where porcine is accepted | Religious and import rules can stop the SKU after the formula is locked | Species declaration · traceability · market / religious restrictions |
| Chicken | Type II | Joint / mobility-focused SKUs | Specify Type II separately from Type I beauty-oriented collagen; raw-material identity and intended application differ | Identity testing · source traceability · Type II specification |
Plant protein peptides are separate protein ingredients and should be specified independently from collagen. See Formula 19 for a hybrid architecture.
Lock on the spec: species (not only “collagen peptides”); tissue origin when the label needs it; Type I / II / III on the COA when the label claims a type; species authentication for Halal, Kosher, pescatarian, or marine-only claims.
If the destination market, retailer, or religion restricts porcine or marine claims, state that on the RFQ before sampling.
A gram of “collagen peptides” on Supplement Facts does not define hydrolysis, size measurement, or lot match. Hydrolysis specification and analytical method sit with source, collagen type, and protein method on any comparable quote.
The MW number itself is not enough. Two ingredients may both claim “2,000 Da” from different hydrolysis processes or different methods. Do not compare “≤2,000 Da,” “average 2,000 Da,” and “2,000 Da distribution” as equivalent specifications. Lock the statistic (average, median, distribution, or cutoff) and the analytical method on the RFQ and COA.
Do not treat “low molecular weight” as a stand-alone absorption claim.
Protein assay: suppliers may use Kjeldahl or Dumas. Nitrogen-to-protein factors and residual moisture also move the number. Use the same agreed method when comparing protein specifications.
| Spec field | Lock | If skipped |
|---|---|---|
| Hydrolysis specification | How the peptide was produced | Same Da claim, different process, odor, and solubility |
| MW statistic | Average, median, distribution, or cutoff | An average is compared to a “less than” cutoff |
| MW analytical method | Method-dependent size result | Quotes look aligned until the first QC dispute |
| Protein assay method | Kjeldahl or Dumas, agreed | Apparent potency gaps that are only method gaps |
| Lot-to-lot range | Not a single sample COA | Launch lot does not match the approved sample |
Once the collagen source, type, daily dose, and format are defined, non-collagen actives can be added or substituted to create a different commercial SKU.
The practical question is not whether an ingredient is “compatible with collagen.” Most are. The practical question is whether the active can be added without creating a new problem in serving size, taste, solubility, stability, or dosage-form capacity.
| Active | Commercial role | Format fit | Development constraint |
|---|---|---|---|
| Vitamin C | Beauty / nutritional positioning | Powder · stick · capsule | Acidity · taste · assay |
| Hyaluronic acid | Skin hydration | Powder · stick · capsule | Dispersion · serving mass |
| Biotin | Hair / skin / nail positioning | Capsule · powder · gummy | Dose · destination-market requirements |
| Ceramides | Skin-barrier positioning | Powder · capsule · softgel | Ingredient form · lipid handling · fill size |
| Keratin | Hair / beauty positioning | Powder · capsule | Source · odor · taste |
| Minerals | Multi-nutrient positioning | Powder · capsule · tablet | Mineral form · taste · pH |
| Botanical extracts | Market-specific differentiation | Powder · capsule | Standardization · taste · color |
| Probiotics | Beauty + digestive positioning | Powder · capsule | Moisture · temperature · shelf-life CFU |
| Astaxanthin | Antioxidant positioning | Softgel / dual delivery | Oil solubility · oxidation |
| CoQ10 | Healthy-aging positioning | Softgel / dual delivery | Oil solubility · oxidation |
| Plant protein peptides | Protein / hybrid beauty positioning | Powder · stick | Source · allergen · flavor · hydrolysis |
These ingredients are adjustment options, not required components.
- Formula 03 can remain collagen + HA + vitamin C, or add biotin for a hair/skin/nail positioning.
- Formula 06 can remain a simple marine beauty powder, or add selected micronutrients for a premium sachet.
- Formula 09 can use astaxanthin through a separate softgel or dual-delivery format rather than forcing an oil-soluble ingredient into a clear drink.
- Formula 13 can be simplified from a multi-source system to two collagen sources if cost, sourcing, or label simplicity is more important.
- Formula 19 can combine collagen with plant peptides; plant proteins remain separate protein ingredients and should never be described as collagen.
Combinations that usually require technical review
Collagen + oil-soluble actives. Astaxanthin and CoQ10 may require a lipid delivery component rather than being dispersed into a clear beverage.
Collagen + probiotics. Moisture, processing temperature, packaging, and end-of-shelf-life CFU need to be considered before selecting the format.
High collagen dose + capsule. A 5–10 g peptide target may require multiple capsules or a different dosage form. Do not select a capsule only because the ingredient list looks short.
Collagen + minerals. Mineral form, taste, pH, and serving mass can become the limiting factors.
Marine collagen + botanicals. The collagen may be soluble while the finished product still fails on odor or aftertaste. Sensory testing belongs on the finished formula, not only on the collagen raw material.
Collagen + plant peptides. Define collagen and plant protein separately for source, specification, allergen status, and hydrolysis method.
Type I + Type II collagen. Do not treat this as simply “more collagen.” Source, collagen type, raw-material specification, and intended use should be defined separately.
If an added active changes the serving size, format, sensory profile, stability requirement, or delivery system, treat it as a formulation change rather than a simple ingredient substitution.
Finished-product performance must be evaluated under the conditions the SKU will actually face: filling, storage, freight, and destination climate.
Format determines the dominant failure mode: powder → moisture/caking; beverage → dispersion/sediment; capsule → fill capacity/flow; softgel → oxidation/leakage.
Collagen peptide powders can be hygroscopic, depending on the raw material and formulation. Marine collagen can develop or intensify off-odors during processing or storage, depending on raw-material quality, residual odor compounds, oxidation, packaging, and formulation. Drink formats can show sediment when particle size, dispersion, concentration, pH, or suspension design is wrong for the serving.
Powder caking after shipment. Moisture into a hygroscopic blend — not a “bad collagen brand.” Ambient humidity during fill, warehouse RH in the destination climate, bulk density and particle size, film or tub barrier, desiccant, and headspace all move the same failure. A cup that mixes in an air-conditioned lab can still cake after ocean freight.
| Failure | Likely cause | Engineering response |
|---|---|---|
| Fish / marine odor after storage | Raw-material odor load · residual odor compounds · oxidation · weak oxygen control · odor after fill | Incoming sensory retain · low-temperature handling where required · oxygen-limited process · odor check after filling |
| Powder caking / hardening | Moisture ingress · water activity · weak barrier · headspace in humid lanes | Lower water activity · foil or equivalent barrier · desiccant as scoped · humidity trial on the finished pack |
| Sediment in a reconstituted drink | Particle size, dispersion, concentration, or incomplete instantization | Granulation or instantization when the serving is a drink · wet-out check in the target liquid |
| Stick-pack leak or hard lumps | Seal contamination with dust · moisture through the film · fulfillment crush | Dust-free seal spec · barrier film · transport simulation |
| Liquid sediment | Particle size, dispersion, concentration, pH, ionic strength, protein interactions, or suspension design | Suspension / dispersion lock |
| Bottle swelling | Microbial activity, gas generation, packaging interaction, or process deviation | Hygiene and process lock · pack compatibility · do not group with sediment |
| Gummy stick or harden | Heat exposure · water-activity drift · moisture migration · matrix composition | Seasonal freight rules · AW and matrix lock |
| Capsule fill-weight drift | Hygroscopic blend · hopper bridging · segregation during transfer or hopper feeding | Pilot on the actual filler — lab beakers do not show bridging |
| Softgel smear / leak | Fill not locked to the gel · heat in lane | Fill and gel lock before artwork |
State the prior defect (caking, odor, sediment, swell) and pack type on the RFQ.
→ Powders · Liquids · Hard capsules · Softgels · Gummies · Moisture / stability · Stick-pack engineering
A bench-stable collagen cup is not a commercial SKU. During pilot production, collagen powder that disperses well in laboratory beakers may still bridge in commercial hoppers or segregate during transfer. Pilot filling verifies blend flow, fill-weight consistency, and packaging compatibility before commercial release.
Typical starting MOQ by format
MOQ varies with formulation, packaging, ingredient cost, and production setup. Confirm on the brief.
| Format | Typical starting MOQ |
|---|---|
| Capsules | 3,000–5,000 units / SKU |
| Gummies | 5,000–10,000 units / SKU |
| Powder / sachets / sticks | 1,000–3,000 units / SKU |
| Liquid / shots / RTD | Project-dependent |
Indicative timing after formula, packaging configuration, and artwork approval
| Stage | Indicative timing |
|---|---|
| Sample | 7–15 days |
| Pilot | 15–25 days |
| Commercial production | Typically 30–45 days |
Calendar moves with formula complexity, packaging configuration, and artwork approval.
| Scale | Typical issues |
|---|---|
| Pilot | Odor after filling · powder set in humidity · stick-seal contamination · cold-water sediment · hopper bridging |
| First commercial lots | Blend segregation · heat-lane gummy texture · jar scoop settle · humidity caking in the destination climate |
| Repeat / industrial volume | Seasonal marine gap · lot flavor drift · fulfillment or ocean-pack failure · pack-material shortage |
Sequence: technical definition → prototype (taste, wet-out, fill) → pack and humidity / transport check → GMP production after formula and artwork lock. A wrong lock in definition (source, type, form, market) is the usual cause of a second prototype.
Get MOQ and Lead Time for This Brief
An available lot does not establish year-round supply continuity. For commercial SKUs, confirm alternate sourcing, seasonal availability, safety stock, and packaging-material lead times.
Lock on the RFQ:
- single-source vs an alternate peptide supplier on the same spec
- seasonal marine sourcing, and odor / color / MW if a backup lot is used
- safety stock versus make-to-order for 12-month listings
- lead time when artwork, film, or bottles — not the peptide — set the date
- packaging inventory (sticks, scoops, desiccant, liners)
- annual volume for dual-source and buffer sizing
Change control. Raw-material or supplier changes should be subject to agreed change-control and notification procedures, including notice before ship if species, hydrolysis, MW method, or pack film changes.
If the listing must stay live through a marine off-season, put annual volume on the RFQ.
Marine raw materials require contaminant testing based on source, market, and specification. A metals pass with the wrong species is still a failed SKU for Halal, Kosher, pescatarian, or marine-only claims.
| Risk | What to require |
|---|---|
| Heavy metals | As · Hg · Pb · Cd on incoming and finished goods as scoped |
| Micro | Incoming + finished-goods panel |
| Identity | Species authentication when the claim needs it |
| Traceability | Lot file: species, hydrolysis record, QC release, retain, shipment |
Retain samples and historical COAs for the same spec — not only the tasting sample.
Label and retailer issues: unsupported beauty or aging claim language for the destination market; “collagen” with no species, type, or hydrolysis disclosure; peptide spec that does not match the COA method; metals fail at import; retailer or marketplace spec rejection; export file incomplete at cargo ready.
Docs pack (project-scoped): spec · COA (identity + assay + MW method + protein method) · metals / micro · traceability · Halal / Kosher if in scope · destination export file list.
Documentation can be scoped to the destination market and customer requirements. Typical destination markets supported: North America · Europe · Southeast Asia · Middle East · cross-border e-commerce.
Packaging decisions affect moisture uptake, freight performance, shelf stability, and customer complaints as much as formulation decisions. Barrier, desiccant, headspace, and oxygen control are specified with the formula.
Applicable manufacturing and certification systems include cGMP, ISO 22000, ISO 9001, HACCP, FSSC 22000, Halal and Kosher, subject to product, facility, and market scope. Halal / Kosher eligibility is determined by the raw-material source, processing controls, and applicable certification scope.
After launch. Complaint assessment starts after the lot code, pack photos, storage conditions, and relevant batch information are received. CAPA follows whatever the retain supports: formula, pack, process, supplier, or logistics.
Typical tickets: powder harden · marine odor rise · gummy stick · flavor drift · color darkening · poor dissolve · leaking sticks · swollen bottles.
Formula confidentiality. NDA · client-coded formulas · restricted document access · controlled handling for exclusive SKUs.
Send this checklist — get a comparable collagen OEM quote
An incomplete RFQ produces a non-comparable quote. Use this checklist before requesting pricing.
- Which formula blueprint (01–20), or “not specified — please recommend”?
- Which collagen source (marine / bovine / porcine / chicken) — and which sources the market or religion forbids?
- Which collagen type (I / II / III), evidenced on the COA?
- Target peptide specification / MW range, if defined (for example ≤2,000 Da or 1,500–3,000 Da) — or “not specified, please recommend”?
- MW statistic and method on the COA (average / distribution / cutoff + method)?
- Target daily serving (grams or milligrams of peptide, not only “1 scoop”)?
- Powder, stick, capsule, softgel, liquid, gummy — taste-first or capsule-first?
- Destination export market and channel (Amazon, DTC, retail, practitioner)?
- Required certifications (Halal / Kosher only where source, process, and cert scope allow)?
- Required COA fields: species, type, hydrolysis, MW statistic + method, protein method, metals, micro?
- Annual volume and whether the listing must stay in stock through marine seasonality?
- Shelf-life and destination climate?
- Known prior defect (caking, odor, sediment, swell, leak)?
- Non-collagen additions (HA, vitamin C, ceramides, plant peptides) — specified as additions, not as collagen types?
Send the Completed Brief · Request Spec + COA Pack
Yes. We can develop against a customer-defined specification or use one of the reference blueprints as the starting point. Provide the collagen source, type, peptide dose, active ingredients, dosage form, target market, and any existing COA or product specification. We can then identify formulation, sourcing, and manufacturing constraints before sampling.
Yes, subject to raw-material availability and analytical-method alignment. A supplier’s COA should be reviewed for source, collagen type, hydrolysis specification, MW statistic and analytical method, protein assay, moisture, and relevant contaminant limits. If the existing specification uses a method that is not directly comparable with our available material, we will identify the difference before quoting.
For an initial quote, we normally need the collagen source/type, target daily dose, dosage form, active ingredients, destination market, packaging format, estimated order quantity, and annual volume. If the formula is not defined, you can send the target positioning and channel instead; we can recommend a starting blueprint.
Customer-nominated collagen can be evaluated for use in the finished product, subject to documentation, incoming specifications, MOQ, availability, and manufacturing compatibility. Provide the supplier name, specification, COA, required inclusion level, and any handling requirements when submitting the RFQ.
High-dose collagen is usually more practical in powder, stick, or sachet formats. If a capsule format is required, the development team will calculate fill weight, capsule size, number of capsules per serving, excipient requirements, and production feasibility before confirming the specification.
Year-round supply depends on source availability, approved supplier capacity, seasonal raw-material conditions, and the required specification. For marine collagen SKUs, we recommend defining an approved specification and alternate-source strategy rather than approving a single lot. Annual volume should be included in the RFQ so supply planning can be evaluated.
Raw-material changes should follow the agreed change-control procedure. Source, species, collagen type, hydrolysis process, MW specification, analytical method, and other critical attributes should be reviewed before an alternate material is introduced into a commercial SKU. Customer notification and approval requirements can be defined in the project documentation.
Yes. Prototype samples can be developed before commercial production. The sample should be evaluated against the agreed specification for taste, appearance, mixability, fill weight, packaging compatibility, and other product-specific criteria. Commercial production follows formula and artwork approval.
The project documentation package can include the product specification, batch COA, identity and assay data, MW method where specified, protein assay method, microbiological and contaminant testing, traceability records, and applicable certification or export documents. The exact document set depends on the raw material, product format, and destination market.
Yes, where the formulation and active load are technically suitable for the target format. Changing serving size or dosage form may require adjustment of excipients, flavor system, flow properties, fill weight, packaging, and stability controls. The original formula should therefore be treated as a formulation architecture rather than a direct one-to-one format conversion.
